On May 13, the United States District Court for the Southern District of Texas ruled against the Federal Trade Commission’s antitrust claims against private equity firm Welsh Carson Anderson & Stowe. The FTC had targeted the firm for its role in forming U.S. Anesthesia Partners, Inc. and consolidating the Texas hospital anesthesia market. This ruling has significant implications for the FTC's strategy against private equity roll-ups in healthcare and sets a new precedent for future antitrust cases.

Read the full article.

About the authors:
Ian Dickinson
Lee K. Van Voorhis